Somatostatin Receptor Therapy for Neuroendocrine Tumours

Created using ChatSlide

This lecture delves into Somatostatin Receptor Therapy, focusing on PRRT as a pivotal treatment for Neuroendocrine Tumours (NET). Explore the therapy's purpose, understand its mechanism, and learn about patient outcomes and risks involved. Discuss patient suitability, safety protocols, and regulatory compliance through EMA and FDA standards. Gain insights into imaging techniques for NET diagnosis and the procedural steps for administering PRRT. The lecture includes real-world applications...